HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emanuela Mazzon Selected Research

Pleurisy (Pleuritis)

1/2012Anti-inflammatory effects of adrenomedullin on acute lung injury induced by Carrageenan in mice.
10/2011CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation.
8/2011The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy.
3/2011Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation.
4/2010GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice.
2/2010Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation.
12/2009PPAR-alpha contributes to the anti-inflammatory activity of 17beta-estradiol.
4/2009Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo.
1/2009Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy.
7/2008Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emanuela Mazzon Research Topics

Disease

145Inflammation (Inflammations)
01/2022 - 01/2002
54Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 02/2005
32Edema (Dropsy)
01/2019 - 05/2002
32Ischemia
12/2014 - 08/2002
31Necrosis
01/2016 - 01/2002
31Shock
06/2012 - 03/2002
29Myelitis
04/2012 - 02/2005
28Colitis
08/2011 - 05/2002
27Reperfusion Injury
11/2015 - 01/2002
27Lung Injury
10/2011 - 01/2002
25Multiple Sclerosis
04/2020 - 08/2013
25Body Weight (Weight, Body)
05/2012 - 10/2002
25Pleurisy (Pleuritis)
01/2012 - 01/2002
24Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2014
20Wounds and Injuries (Trauma)
03/2022 - 07/2002
19Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2011 - 05/2002
18Neoplasms (Cancer)
10/2021 - 06/2004
18Pancreatitis
07/2012 - 05/2002
15Pneumonia (Pneumonitis)
10/2011 - 03/2004
15Multiple Organ Failure (MODS)
09/2011 - 10/2002
14Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2020 - 08/2013
13Arthritis (Polyarthritis)
11/2019 - 10/2002
12Alzheimer Disease (Alzheimer's Disease)
12/2021 - 12/2016
10Neuroinflammatory Diseases
12/2021 - 01/2011
10Parkinson Disease (Parkinson's Disease)
10/2021 - 01/2012
10Periodontitis
08/2017 - 06/2005
10Diarrhea
10/2015 - 05/2002
10Experimental Arthritis
12/2011 - 01/2002
10Septic Shock (Toxic Shock Syndrome)
07/2011 - 11/2002
9Hypoxia (Hypoxemia)
05/2020 - 12/2004
9Hemorrhage
05/2012 - 05/2002
9Weight Loss (Weight Reduction)
02/2009 - 07/2002
7Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2021 - 01/2015
6Disease Progression
11/2021 - 12/2016

Drug/Important Bio-Agent (IBA)

533-nitrotyrosineIBA
10/2015 - 05/2002
50CytokinesIBA
10/2021 - 06/2002
41Peroxidase (Myeloperoxidase)IBA
11/2011 - 02/2003
39Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2010 - 02/2003
33CarrageenanIBA
01/2012 - 01/2002
25NF-kappa B (NF-kB)IBA
12/2014 - 01/2002
24Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2014 - 01/2002
23EnzymesIBA
07/2020 - 01/2002
23DinitrobenzenesIBA
08/2011 - 07/2002
22Proteins (Proteins, Gene)FDA Link
09/2019 - 04/2006
22ZymosanIBA
09/2011 - 01/2002
21LigandsIBA
06/2012 - 12/2003
20Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2015 - 01/2002
202,4-dinitrofluorobenzene sulfonic acidIBA
08/2011 - 07/2002
19Sulfonic AcidsIBA
08/2011 - 05/2002
18Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2019 - 12/2004
18Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2014 - 01/2002
16CeruletideIBA
07/2012 - 05/2002
16PPAR alphaIBA
01/2010 - 10/2004
15GlucocorticoidsIBA
02/2017 - 11/2004
14Transcription Factors (Transcription Factor)IBA
10/2021 - 01/2002
14Interleukin-1beta (Interleukin 1 beta)IBA
04/2009 - 01/2002
13Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 07/2002
13AntioxidantsIBA
03/2021 - 07/2003
13Biological ProductsIBA
04/2020 - 06/2004
13Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2019 - 01/2002
13Lipase (Acid Lipase)FDA Link
07/2012 - 05/2002
13AmylasesFDA Link
07/2012 - 05/2002
13Peroxynitrous Acid (Peroxynitrite)IBA
11/2010 - 11/2002
13DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2010 - 02/2005
12Pharmaceutical PreparationsIBA
06/2021 - 04/2006
12moringinIBA
05/2021 - 01/2016
12Neuroprotective AgentsIBA
01/2018 - 02/2011
11Bleomycin (Blenoxane)FDA LinkGeneric
07/2011 - 05/2005
11Poly Adenosine Diphosphate RiboseIBA
07/2011 - 08/2002
10DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2002
10Collagen Type II (Type II Collagen)IBA
11/2019 - 10/2002
10thioglucosidaseIBA
04/2019 - 08/2013
10P-SelectinIBA
10/2015 - 01/2002
9MelatoninIBA
05/2020 - 04/2005
9isothiocyanic acidIBA
04/2019 - 01/2015
9Interleukin-6 (Interleukin 6)IBA
01/2011 - 06/2002
8Macrophage Migration-Inhibitory FactorsIBA
03/2020 - 01/2018
8InterleukinsIBA
12/2019 - 08/2002
8Dexamethasone (Maxidex)FDA LinkGeneric
09/2015 - 06/2005
8AcidsIBA
04/2011 - 07/2002
8ProstaglandinsIBA
07/2009 - 05/2002
7LipopolysaccharidesIBA
03/2022 - 03/2003
7GlucosinolatesIBA
01/2022 - 01/2016
7CannabidiolIBA
06/2020 - 10/2015
7CannabinoidsIBA
11/2019 - 11/2014
7PolyphenolsIBA
04/2016 - 05/2005
7Fas Ligand Protein (Fas Ligand)IBA
11/2011 - 11/2006
7Nitric Oxide Synthase (NO Synthase)IBA
11/2011 - 05/2002
7Tyrosine (L-Tyrosine)FDA Link
05/2011 - 11/2005
7Superoxides (Superoxide)IBA
11/2010 - 07/2002
7Uridine Triphosphate (UTP)IBA
02/2010 - 02/2005
7salicylhydroxamic acid (SHAM)IBA
01/2010 - 01/2004
7Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2007 - 01/2002
6MicroRNAs (MicroRNA)IBA
12/2021 - 08/2019
6Mitogen-Activated Protein KinasesIBA
10/2021 - 04/2008
6Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2005

Therapy/Procedure

38Therapeutics
11/2021 - 01/2002
34Laminectomy
01/2015 - 02/2005
15Intraperitoneal Injections
07/2012 - 05/2002
7Ligation
05/2011 - 10/2005